Wells Fargo Maintains Equal-Weight on Qiagen, Raises Price Target to $60

Wells Fargo analyst Dan Leonard maintains Qiagen (NYSE:QGEN) with a Equal-Weight and raises the price target from $58 to $60.Wells Fargo analyst Dan Leonard maintains Qiagen (NYSE:QGEN) with a Equal-Weight and raises the price target from $58 to $60.